Wlds-mediated protection of dopaminergic fibers in an animal model of Parkinson disease. Export

@article{citeulike:1343028, abstract = {Parkinson disease (PD) is characterized by the progressive degeneration of substantia nigra dopaminergic neurons projecting to the striatum. Since the deficit in striatal dopamine is the main cause of PD symptoms, it appears critical to preserve axon terminals. Significant axon protection from peripheral nerve Wallerian degeneration is observed in Wlds mice, a phenotype conferred by a spontaneous dominant mutation. To assess any Wlds-mediated rescue of dopamine fibers in a PD model, the nigrostriatal pathway of Wlds mice was lesioned with 6-hydroxydopamine (6-OHDA), a catecholaminergic neurotoxin. Following 6-OHDA injection in the medial forebrain bundle, Wlds mice showed remarkable dopamine fiber protection in the striatum. Drug-induced rotational behavior confirmed the nigrostriatal fiber ability to release dopamine, although revealing an abnormal neurotransmitter control presumably due to disrupted axonal transport. Following 6-OHDA injection in the midstriatum, only a protection trend was observed. Strikingly, no protection of Wlds nigral dopaminergic cell bodies was obtained following either nigrostriatal lesion. Besides showing subtle differences in the degeneration process between subcellular compartments, the reported Wlds-mediated protection of the dopamine axon terminals in an animal model of PD may lead to the understanding of mechanisms underlying axon loss and to the development of new therapeutic approaches.}, address = {Institute of Neurosciences, Swiss Federal Institute of Technology Lausanne, EPFL, Lausanne, Switzerland.}, author = {Sajadi, A. and Schneider, B. L. and Aebischer, P.}, citeulike-article-id = {1343028}, citeulike-linkout-0 = {http://dx.doi.org/10.1016/j.cub.2004.01.053}, citeulike-linkout-1 = {http://view.ncbi.nlm.nih.gov/pubmed/14972684}, citeulike-linkout-2 = {http://www.hubmed.org/display.cgi?uids=14972684}, day = {17}, doi = {10.1016/j.cub.2004.01.053}, issn = {0960-9822}, journal = {Curr Biol}, keywords = {animal, cns, model, parkinson, wlds}, month = {February}, number = {4}, pages = {326--330}, posted-at = {2007-05-30 15:12:45}, priority = {0}, title = {Wlds-mediated protection of dopaminergic fibers in an animal model of Parkinson disease.}, url = {http://dx.doi.org/10.1016/j.cub.2004.01.053}, volume = {14}, year = {2004} }

TY - JOUR ID - citeulike:1343028 L3 - citeulike-article-id:1343028 N2 - Parkinson disease (PD) is characterized by the progressive degeneration of substantia nigra dopaminergic neurons projecting to the striatum. Since the deficit in striatal dopamine is the main cause of PD symptoms, it appears critical to preserve axon terminals. Significant axon protection from peripheral nerve Wallerian degeneration is observed in Wlds mice, a phenotype conferred by a spontaneous dominant mutation. To assess any Wlds-mediated rescue of dopamine fibers in a PD model, the nigrostriatal pathway of Wlds mice was lesioned with 6-hydroxydopamine (6-OHDA), a catecholaminergic neurotoxin. Following 6-OHDA injection in the medial forebrain bundle, Wlds mice showed remarkable dopamine fiber protection in the striatum. Drug-induced rotational behavior confirmed the nigrostriatal fiber ability to release dopamine, although revealing an abnormal neurotransmitter control presumably due to disrupted axonal transport. Following 6-OHDA injection in the midstriatum, only a protection trend was observed. Strikingly, no protection of Wlds nigral dopaminergic cell bodies was obtained following either nigrostriatal lesion. Besides showing subtle differences in the degeneration process between subcellular compartments, the reported Wlds-mediated protection of the dopamine axon terminals in an animal model of PD may lead to the understanding of mechanisms underlying axon loss and to the development of new therapeutic approaches. IS - 4 JF - Curr Biol SN - 0960-9822 AD - Institute of Neurosciences, Swiss Federal Institute of Technology Lausanne, EPFL, Lausanne, Switzerland. EP - 330 TI - Wlds-mediated protection of dopaminergic fibers in an animal model of Parkinson disease. VL - 14 SP - 326 KW - animal KW - cns KW - model KW - parkinson KW - wlds AU - Sajadi, A AU - Schneider, BL AU - Aebischer, P PY - 2004/02/17/ UR - http://dx.doi.org/10.1016/j.cub.2004.01.053 ER -